Inge Lues

Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer’s disease: results of a randomized, double-blind, placebo-controlled phase 2a study

Philip Scheltens, Merja Hallikainen, Timo Grimmer et al. · Alzheimer s Research & Therapy · 2018 · 127 citations · Full text

The Two Mechanisms of Action of Racemic Cardiotonic EMD 53998, Calcium Sensitization and Phosphodiesterase Inhibition, Reside in Different Enantiomers

Inge Lues, Norbert Beier, Rochus Jonas et al. · Journal of Cardiovascular Pharmacology · 1993 · 79 citations

Cardiac Muscle, Cardiovascular Pharmacology, Cardiovascular Function +18

Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer’s Disease—Studies on Relation to Effective Target Occupancy

Torsten Hoffmann, Antje Meyer, Ulrich Heiser et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 71 citations · Full text

Postjunctional ?-adrenoceptors in the isolated saphenous vein of the rabbit

Hans-Joachim Sch�mann, Inge Lues · Naunyn-Schmiedeberg s Archives of Pharmacology · 1983 · 68 citations

Adrenal Gland, Physiology, Electrophysiology +5

Effect of removing the endothelial cells on the reactivity of rat aortic segments to different ?-adrenoceptor agonists

Inge Lues, Hans-Joachim Sch�mann · Naunyn-Schmiedeberg s Archives of Pharmacology · 1984 · 65 citations

Endothelial Cells, Cardiovascular Disease, Medicine +10